Takeda makes $61 billion bid for drugmaker Shire: sources

LONDON (Reuters) - Takeda Pharmaceutical has made a bid for Shire that values the London-listed drugmaker at around $61 billion, two sources with direct knowledge of the matter told Reuters.

Takeda makes $61 billion bid for drugmaker Shire: sources
Read More


Bagikan Berita Ini